Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for moderate to severe COVID-19
RBR-10k2w2c5Phase 3Completed
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of colchicine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hospital das Clínicas de Ribeirão Preto. Started Oct 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-10k2w2c5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10k2w2c5.